In the past 52-week period, shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) have moved within the range of $6.70 to $20.94. On the stock’s most recent trading day, the company’s shares ended the regular session at $20.85, which is 0.43% lower than its 52-week high.
Corcept Therapeutics Incorporated (CORT) has demonstrated a 20-day simple moving average (SMA) of 16.43%, and a 50-day SMA of 16.71%. This public company’s current market capitalization stands at $2.39 billion.Analyzing Consensus Estimates, Sales Revenue and Net Income
When thinking about buying shares in a public company, it is useful to gauge the average enthusiasm level of Wall Street analysts for that specific stock. According to the latest data, the consensus recommendation for Corcept Therapeutics Incorporated (CORT) is Outperform.
When it comes to quarterly financial results, publicly-traded companies usually post earnings and revenue figures that fall somewhat above or below the average Wall Street estimate. In the most recent quarterly financial report, for the quarter ending Sep. 2017, Corcept Therapeutics Incorporated (CORT) delivered a 0.71% surprise with its net revenue. Sales reached $0.04 billion during the three-month period, compared to the average analyst estimate of $0.04 billion.Ownership at Corcept Therapeutics Incorporated (CORT), According to Most Recent SEC Filings
Investors can gain useful insight on institutional ownership within a public company by taking a look at the organization’s most recent 13F filings. Corcept Therapeutics Incorporated (CORT) has 0 billion shares outstanding currently, 64.74% of which belong to institutional investors. Those institutional holdings amount to $1.54 billion.
Additionally, according to the most recent 13F filing from Corcept Therapeutics Incorporated (CORT), there were 47 new positions totaling 2,902,587 shares of the company’s stock. There were 14 sold out positions, on the other hand, totaling 706,344 shares.Short, Medium and Long Term Indicators
By looking at a stock’s average trade volume – in the short, medium, and long terms – we can gain a better understanding of investor sentiment and trading activity. Corcept Therapeutics Incorporated (CORT) has had a 20-day average volume of 2,586,265 shares, with an average of 100% of short term indicators pointed at Buy.
The stock’s 50-day average volume has been 1,838,490 shares, with an average of 100% of medium term indicators pointing toward Buy. Finally, its 100-day average volume is 1,678,857 shares with 100% of long-term indicators pointing to Buy.